Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 1, 2004, Pages 33-37

  Yamauchi, H ^a,b   Okazawa, H ^b   Kishibe, Y ^b   Sugimoto, K ^b   Takahashi, M ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b Shiga Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTERY DILATATION; ARTICLE; BRAIN BLOOD VOLUME; BRAIN CIRCULATION; BRAIN OXYGEN CONSUMPTION; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ACETAZOLAMIDE; AGED; ANTICONVULSANTS; BRAIN; CAROTID STENOSIS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OXYGEN; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATION;

EID: 0346494828     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 15O positron emission tomography. Stroke 1981;12:454-9.
2. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991;29:231-40.
3. Yamauchi H, Fukuyama H, Nagahama Y, et al. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry 1996;61:18-25.
4. Yamauchi H, Fukuyama H, Nagahama Y, et al. Significance of increased oxygen extraction fraction in 5-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999;40:1992-8.
5. Grubb Jr RL, Derdeyn CP, Fritsch SM, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998;280:1055-60.
6. Klijn CJ, Kappelle LJ, Tulleken CA, et al. Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke 1997;28:2084-93.
7. Derdeyn CP, Grubb Jr RL, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999;53:251-9.
8. Adams Jr HP, Powers WJ, Grubb Jr RL, et al. Preview of a new trial of extracranial-to-intracranial arterial anastomosis: the carotid occlusion surgery study. Neurosurg Clin N Am 2001;12:613-624.
9. Yonas H, Pindzola RR. Physiological determination of cerebrovascular reserves and its use in clinical management. Cerebrovoscular and Brain Metabolism Reviews 1994;6:325-40.
10. Yonas H, Smith HA, Durham SR, et al. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483-9.
11. Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001;124:457-67.
12. Kuroda S, Houkin K, Kamiyama H, et al. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110-16.
13. Ogasawara K, Ogawa A, Terasaki K, et al. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab 2002;22:1142-8.
14. Yokota C, Hasegawa Y, Minematsu K, et al. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998;29:640-4.
15. Klijn G, Kappelle LJ, van Huffelen AC, et al. Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology 2000;55:1806-12.
16. DeGardo T, Turkington T, Williams J, et al. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-1406.
17. 15O gas and water. J Cereb Blood Flow Metab 2001;21:793-803.
18. Votaw JR, Shulman SD. Performance evaluation of the Pico-Coun flow-through detector for use in cerebral blood flow PET studies. J Nucl Med 1998;39:509-15.
19. Okazawa H, Yamauchi H, Sugimoto K, et al. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001;21:1472-9.
20. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980;4:727-36.
21. Lammertsma AA, Jones T. Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain. 1. Description of the method. J Cereb Blood Flow Metab 1983;3:416-24.
22. 15O. I. Theory and error analysis. J Nucl Med 1983;24:782-9.
23. 15O. II. Implementation and validation. J Nucl Med 1983;24:790-8.
24. Kretschmann HJ, Weinrich W. Neuroanatomy and cranial computed tomography. New York: Thieme, 1986:70-4.
25. Yamauchi H, Fukuyama H, Kimura J, et al. Hemodynamics in internal carotid artery occlusion examined by positron emission tomography. Stroke 1990;21:1400-6.
26. Yamauchi H, Okazawa H, Kishibe Y, et al. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease. Eur J Nucl Med Mol Imaging 2002;29:1349-56.
27. Imaizumi M, Kitagawa K, Hashikawa K, et al. Detection of misery perfusion with split-dose 1231-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases. Stroke 2002;33:2217-23.
28. Feeney DM, Baron JC. Diaschisis. Stroke 1986;17:817-30.
29. Sette G, Baron J, Mazoyer B, et al. Local brain haemodynamics and oxygen metabolism in cerebrovasculor disease. Brain 1989;112:931-51.
30. Yamauchi H, Fukuyama H, Kimura J. Hemodynamic and metabolic changes in crossed cerebellar hypoperfusion. Stroke 1992;23:855-60.
31. 133 xenon injection technique. J Neurol Neurosurg Psychiatry 1988;51:1045-50.
32. 15O with PET. J Nucl Med 2003;44:520-5.